Thursday, September 21, 2017 8:01:28 AM
I think the best case scenario is that they outline a capital plan to enable them to grow revenue to levels that we're all expecting given the initial $78mm contract (and now they have a ~$30mm contract in Vietnam).
The volume in absolute terms wasn't that big, particularly in relation to the shares outstanding. That said, if you looked at L2 (see otcmarkets) there wasn't much buying support (though sellers weren't pounding it at all costs for the most part).
I bought some more opportunistically. Even though I'm displeased at the company's investor relations practices, the current valuation is absurdly low. Just need to see modest improvement in execution and a sound capital raising plan and the stock will re-rate a lot higher.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM